FDC Ltd 531599
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 461.30
- Day Range
- INR 453.25–463.75
- 52-Week Range
- INR 281.40–487.50
- Bid/Ask
- INR 453.25 / INR 454.00
- Market Cap
- INR 73.79 Bil
- Volume/Avg
- 3,869 / 15,765
Key Statistics
- Price/Earnings (Normalized)
- 28.99
- Price/Sales
- 3.96
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 2.06%
Company Profile
FDC Ltd is an Indian-based pharmaceutical company with USFDA and UK-MHRA-approved API and formulations manufacturing facilities. It has its presence in numerous therapeutic segments: Anti-infectives, Gastro-Intestinal, Vitamins/Minerals/Nutrients, Ophthalmology/Otologicals, Cardiac, Dermatology, Respiratory, Gynaecology, and Others. The company's brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. The majority of the revenue is generated domestically.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 6,452
- Website
- https://www.fdcindia.com
Comparables
Valuation
|
Metric
|
531599
|
524348
|
543434
|
|---|---|---|---|
Price/Earnings (Normalized) | 28.99 | 26.52 | 27.03 |
Price/Book Value | 3.81 | 3.86 | 4.39 |
Price/Sales | 3.96 | 1.77 | 6.07 |
Price/Cash Flow | 32.58 | 19.98 | 30.87 |
Price/Earnings
531599
524348
543434
Financial Strength
|
Metric
|
531599
|
524348
|
543434
|
|---|---|---|---|
Quick Ratio | 1.70 | 0.87 | 3.14 |
Current Ratio | 3.04 | 1.61 | 6.26 |
Interest Coverage | 95.60 | 8.39 | 192.48 |
Quick Ratio
531599
524348
543434
Profitability
|
Metric
|
531599
|
524348
|
543434
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
531599
524348
543434
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Tjbpcqdfgs | Fnfn | $73.0 Bil | |
MKKGY
| Merck KGaA ADR | Vgmmvxbw | Zzkgfn | $69.8 Bil | |
HLN
| Haleon PLC ADR | Ymrlbygw | Psmy | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Rzmwpnjw | Ntpl | $14.6 Bil | |
VTRS
| Viatris Inc | Sntmwppr | Pvc | $14.0 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Yvfxsktml | Ccwp | $12.6 Bil | |
CTLT
| Catalent Inc | Wxbnjfh | Ywbkn | $10.2 Bil | |
PRGO
| Perrigo Co PLC | Ypqwqbg | Glhx | $4.4 Bil | |
CURLF
| Curaleaf Holdings Inc | Gqlyhwhw | Dvmy | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ktvrdhtnt | Tgctppb | $3.6 Bil |